333 related articles for article (PubMed ID: 19346963)
21. Diffusion-weighted echo-planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft-tissue sarcomas.
Schnapauff D; Zeile M; Niederhagen MB; Fleige B; Tunn PU; Hamm B; Dudeck O
J Magn Reson Imaging; 2009 Jun; 29(6):1355-9. PubMed ID: 19472392
[TBL] [Abstract][Full Text] [Related]
22. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
Li S; Sun F; Jin ZY; Xue HD; Li ML
J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
[TBL] [Abstract][Full Text] [Related]
23. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
[TBL] [Abstract][Full Text] [Related]
24. Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis.
Bäuerle T; Bartling S; Berger M; Schmitt-Gräff A; Hilbig H; Kauczor HU; Delorme S; Kiessling F
Eur J Radiol; 2010 Feb; 73(2):280-7. PubMed ID: 19070445
[TBL] [Abstract][Full Text] [Related]
25. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging.
Thoeny HC; De Keyzer F; Vandecaveye V; Chen F; Sun X; Bosmans H; Hermans R; Verbeken EK; Boesch C; Marchal G; Landuyt W; Ni Y
Radiology; 2005 Nov; 237(2):492-9. PubMed ID: 16192323
[TBL] [Abstract][Full Text] [Related]
26. Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations.
Eccles CL; Haider EA; Haider MA; Fung S; Lockwood G; Dawson LA
Acta Oncol; 2009; 48(7):1034-43. PubMed ID: 19634060
[TBL] [Abstract][Full Text] [Related]
27. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla.
Deng J; Rhee TK; Sato KT; Salem R; Haines K; Paunesku T; Mulcahy MF; Miller FH; Omary RA; Larson AC
Invest Radiol; 2006 Apr; 41(4):410-4. PubMed ID: 16523024
[TBL] [Abstract][Full Text] [Related]
28. Monitoring T2 and ADC at 9.4 T following fractionated external beam radiation therapy in a mouse model.
Larocque MP; Syme A; Yahya A; Wachowicz K; Allalunis-Turner J; Fallone BG
Phys Med Biol; 2010 Mar; 55(5):1381-93. PubMed ID: 20150684
[TBL] [Abstract][Full Text] [Related]
29. Diffusion-weighted whole-body MR screening.
Vilanova JC; Barceló J
Eur J Radiol; 2008 Sep; 67(3):440-7. PubMed ID: 18430538
[TBL] [Abstract][Full Text] [Related]
30. The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro.
Köpf-Maier P
In Vivo; 1998; 12(3):275-88. PubMed ID: 9706471
[TBL] [Abstract][Full Text] [Related]
31. Ischemic lesion volume determination on diffusion weighted images vs. apparent diffusion coefficient maps.
Bråtane BT; Bastan B; Fisher M; Bouley J; Henninger N
Brain Res; 2009 Jul; 1279():182-8. PubMed ID: 19427841
[TBL] [Abstract][Full Text] [Related]
32. Apparent diffusion coefficient in the aging mouse brain: a magnetic resonance imaging study.
Rau PR; Sellner J; Heiland S; Plaschke K; Schellinger PD; Meyding-Lamadé UK; Lamadé WR
Life Sci; 2006 Feb; 78(11):1175-80. PubMed ID: 16213530
[TBL] [Abstract][Full Text] [Related]
33. Myeloablative and immunosuppressive properties of treosulfan in mice.
Sjöö F; Hassan Z; Abedi-Valugerdi M; Griskevicius L; Nilsson C; Remberger M; Aschan J; Concha H; Gaughan U; Hassan M
Exp Hematol; 2006 Jan; 34(1):115-21. PubMed ID: 16413398
[TBL] [Abstract][Full Text] [Related]
34. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
[TBL] [Abstract][Full Text] [Related]
35. [MRI diagnosis in longitudinal stress fractures: differential diagnosis of Ewing sarcoma].
Pauleit D; Sommer T; Textor J; Flacke S; Hasan C; Steuer K; Emous D; Schild H
Rofo; 1999 Jan; 170(1):28-34. PubMed ID: 10071641
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Sharma U; Danishad KK; Seenu V; Jagannathan NR
NMR Biomed; 2009 Jan; 22(1):104-13. PubMed ID: 18384182
[TBL] [Abstract][Full Text] [Related]
37. Diffusion weighted imaging of pediatric and adolescent malignancies with regard to detection and delineation: initial experience.
Alibek S; Cavallaro A; Aplas A; Uder M; Staatz G
Acad Radiol; 2009 Jul; 16(7):866-71. PubMed ID: 19394872
[TBL] [Abstract][Full Text] [Related]
38. Correlation of diffusion-weighted imaging data with apoptotic and proliferation indexes in CT26 colorectal tumor homografts in balb/c mouse.
Zhang XY; Sun YS; Tang L; Xue WC; Zhang XP
J Magn Reson Imaging; 2011 May; 33(5):1171-6. PubMed ID: 21509876
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
40. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma.
Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L
J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
